SCHEMBL5457542

SCHEMBL5457542

CC(=O)c1c(-c2ccc(F)cc2)nn2c(N3CCCC3)cccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
PARP1 P09874 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
HTT P42858 1/20 0.36
KCNK3 O14649 1/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
ALDH1A1 P00352 2/20 0.35
TP53 P04637 2/20 0.35
HPGD P15428 2/20 0.35
MAPK1 P28482 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6105801 0.86 ALDH1A1 (0.43) KMT2AMEN1NPSR1HTTNPC1
SCHEMBL5459574 0.83 TDP1 (0.42) MAPK14KMT2AMEN1NPSR1HTT
SCHEMBL5459581 0.83 TDP1 (0.42) MAPK14KMT2AMEN1NPSR1HTT
SCHEMBL6107074 0.82 SMN1; SMN2 (0.38) KMT2AMEN1HTTNPC1RAB9A
SCHEMBL5459554 0.76 ALOX5 (0.42) MAPK14CSNK1DCSNK1ENPC1RAB9A
SCHEMBL6105119 0.71 ALDH1A1 (0.42) KMT2AMEN1NPSR1HTTALDH1A1
SCHEMBL6105126 0.71 ALDH1A1 (0.42) KMT2AMEN1NPSR1HTTALDH1A1
SCHEMBL5452130 0.71 AXL (0.38) MAPK14KMT2AMEN1HTTNPC1
SCHEMBL5379439 0.71 MAPK14 (0.54) MAPK14KMT2AMEN1NPSR1HTT
SCHEMBL5448879 0.70 MAPK14 (0.42) MAPK14CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287721-A1 Pyrazolopyridinyl pyridine BOYD F LESLIE 2007-12-13 US disclosed
EP-1377573-B1 PYRAZOLOPYRIDINE DERIVATIVES GLAXO GROUP LTD (GB) 2005-07-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287721-A1 Pyrazolopyridinyl pyridine CYP3A5, CYP2C19, CYP3A4 MAPK14 2533/4885KMT2A 3949/4885MEN1 1762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.